Over-expressions of AMPK subunits in ovarian carcinomas with significant clinical implications
about
Identification of druggable cancer driver genes amplified across TCGA datasetsNutraceuticals in Parkinson's DiseasePast strategies and future directions for identifying AMP-activated protein kinase (AMPK) modulatorsDissecting the Dual Role of AMPK in Cancer: From Experimental to Human StudiesReduced expression of AMPK-β1 during tumor progression enhances the oncogenic capacity of advanced ovarian cancerDysregulation of RNA polymerase I transcription during disease.An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinomaGlucose-based regulation of miR-451/AMPK signaling depends on the OCT1 transcription factor.Rare coding variants and X-linked loci associated with age at menarche.Prognostic significance of AMPK in human malignancies: A meta-analysis.When Anti-Aging Studies Meet Cancer Chemoprevention: Can Anti-Aging Agent Kill Two Birds with One Blow?Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK.CD74: a new prognostic factor for patients with malignant pleural mesothelioma.AMPK: a contextual oncogene or tumor suppressor?Activators of AMPK: not just for type II diabetes.Screening methods for AMP-activated protein kinase modulators: a patent review.AMPK β1 reduces tumor progression and improves survival in p53 null mice.Functional characterization of AMP-activated protein kinase signaling in tumorigenesis.PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells.AMPK and Cancer.Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.Consensus reference gene(s) for gene expression studies in human cancers: end of the tunnel visible?
P2860
Q21090621-B7E21115-7247-4BFC-AC35-AEC10B725F96Q26752769-E9722382-B6F3-4212-89F0-3776B0CDC3ECQ26864679-DF8AF730-D64F-4467-BC19-E9342AE4593AQ28081491-F0642D7A-B984-47B6-ABB4-90ADB1FDB3ECQ33590428-E76A865B-FD98-4948-B14F-05F2B908935DQ34645436-AD553A65-23A4-4360-A03A-330B25062C99Q34926232-AB6973E5-1388-4825-89E3-D4F7D5F00D87Q35607018-D6DED96F-30D0-47B8-96AB-7D7A9497C8DAQ35961979-7434629F-F4F3-4556-BCED-11312BD5CD7DQ36157437-203EB000-3F36-4050-8FF1-58188D057031Q36442945-A2BE5110-876A-49A9-82FB-0C347E50C39AQ36949580-D4968C4C-3019-481F-98D6-F911907252F9Q37376505-BC46F45B-D9D5-4F23-A88C-87C886C024C4Q37711647-4FC2081A-DE70-4D96-8DDC-44071CB50E77Q38104227-1250A3C0-05B7-42CA-9ADA-05F83F213A71Q38243893-6C9B29BA-66EF-4943-86D3-5E66E0266733Q38298547-B25D93E0-F543-426B-B5E7-884609C4DD04Q38764024-19088C2D-68F4-4EB5-BA91-01263D3D640DQ38807302-3FDCB48E-9F42-42DB-8F86-76F125DC29B9Q38831430-7BBB26A5-BEF2-4F9C-92CE-4727A384091EQ38998413-B852F95F-6C92-407D-B887-7A1C8F1E5607Q50915266-1CD4F407-7371-4760-9FEB-E8DCE43DF9B1Q53527300-017DC87C-522C-4675-BA6C-5E87C4216AE3
P2860
Over-expressions of AMPK subunits in ovarian carcinomas with significant clinical implications
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Over-expressions of AMPK subun ...... nificant clinical implications
@ast
Over-expressions of AMPK subun ...... nificant clinical implications
@en
Over-expressions of AMPK subun ...... nificant clinical implications
@nl
type
label
Over-expressions of AMPK subun ...... nificant clinical implications
@ast
Over-expressions of AMPK subun ...... nificant clinical implications
@en
Over-expressions of AMPK subun ...... nificant clinical implications
@nl
prefLabel
Over-expressions of AMPK subun ...... nificant clinical implications
@ast
Over-expressions of AMPK subun ...... nificant clinical implications
@en
Over-expressions of AMPK subun ...... nificant clinical implications
@nl
P2093
P2860
P356
P1433
P1476
Over-expressions of AMPK subun ...... nificant clinical implications
@en
P2093
David W Chan
Hextan Ys Ngan
Pui M Chiu
Vincent Ws Liu
P2860
P2888
P356
10.1186/1471-2407-12-357
P407
P577
2012-08-16T00:00:00Z
P5875
P6179
1004784114